Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viatom is a private Chinese healthcare technology and medical device company focused on connected vital-sign monitoring, wearable health devices, and telehealth-enabling platforms. The company develops and manufactures products such as pulse oximeters, ECG/EKG monitors, blood pressure monitors, portable vital-sign monitors, ultrasound devices, and related remote monitoring solutions for both home and professional use. Viatom also offers software and data infrastructure including its AI-ECG Platform and ViHub open platform to support ECG analysis, integration with third-party healthcare services, and remote patient monitoring workflows. The company appears to operate as a Lepu Medical-affiliated business and emphasizes R&D, wearable medical technology, and export-oriented commercialization across multiple countries. Overall, Viatom is best characterized as a commercial-stage digital health and medical device manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viatom.